Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 December 2020
Health sciences
The more than 100 medical students who graduated virtually from the University of the Free State (UFS) Faculty of Health Sciences on Monday (14 December), graduated with a pass rate of 98% in a tumultuous year dominated by the COVID-19 pandemic. The MB ChB class of 2020 – a total of 104 students from the School of Clinical Medicine – graduated virtually on Monday due to COVID-19.

The more than 100 medical students who graduated virtually from the University of the Free State (UFS) Faculty of Health Sciences on Monday (14 December), graduated with a pass rate of 98% in a tumultuous year dominated by the COVID-19 pandemic.

The MB ChB class of 2020 – a total of 104 students from the School of Clinical Medicine – graduated virtually on 14 December due to COVID-19. Another virtual graduation is scheduled for 4 January 2021.

An uncomfortable reality
Dr Lynette van der Merwe, undergraduate medical programme director in the School of Clinical Medicine at the UFS, congratulated the latest UFS doctors on their success. Said Dr Van der Merwe: “In a tumultuous year dominated by the COVID-19 pandemic, this group of final-year medical students refused to give in to the pressure and disruption of national lockdown, emergency remote teaching, an adjusted academic calendar, and frontline exposure as healthcare professionals in training.”  

“They persevered against all odds, faced up to an uncomfortable reality, and showed remarkable resilience.”

According to Dr Van der Merwe, the class of 2020 completed the gruelling five-year medical programme with a pass rate of 98,3%, impressing external examiners who commented on their respectful attitude towards patients and thorough knowledge and skill.  

“The School of Clinical Medicine and Faculty of Health Sciences are immensely proud of our new colleagues and look forward to their contribution to the future of healthcare in South Africa. This achievement would not have been possible without the unwavering commitment of the academic and support staff who guided our students and led the way for them to achieve a life-long dream.”  

“We look back with gratitude on a year that required more than the usual amount of adaptability, creativity, innovation, faith, patience, bravery, and endurance.  It is these qualities that set apart the doctors who graduate from the UFS, and those who train them,” says Dr Van der Merwe.

Hope for the future
She says while COVID-19 is still a harsh reality and the future holds much uncertainty, 2020 has shown that there is hope when we face challenges with grace under pressure, and a firm belief in our goals and values. “Class of 2020, may you continue to rise above fear, chaos and disappointment, may you take heart and walk your journey with strength, may you bring healing to our people and lead us well.”

Drs Kaamilah Joosub and Lynette Upman, who also graduated on Monday, were awarded the prestigious Bongani Mayosi Medical Students Academic Prize – a national award which aims to recognise final-year medical students who epitomise the academic, legendary, and altruistic life of the late Prof Mayosi. The awards are presented to final-year MB ChB students from all South African medical faculties. This is the first year it has been awarded.

View the virtual graduation

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept